N@N

Matthew Harrison Maintained (BHVN) at Hold with Increased Target to $145 on, Oct 19th, 2021

Matthew Harrison of Morgan Stanley, Maintained "Biohaven Ltd." (BHVN) at Hold with Increased Target from $107 to $145 on, Oct 19th, 2021.

Matthew has made no other calls on BHVN in the last 4 months.

There are 7 other peers that have a rating on BHVN. Out of the 7 peers that are also analyzing BHVN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Esther Rajavelu of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $109 on, Tuesday, August 10th, 2021

These are the ratings of the 6 analyists that currently disagree with Matthew

---

• Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $160 on, Wednesday, October 6th, 2021
• Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, October 6th, 2021
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $156 on, Tuesday, October 5th, 2021
• Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $165 on, Monday, September 13th, 2021
• Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $150 on, Tuesday, August 3rd, 2021
• Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $134 on, Monday, July 12th, 2021

Contributing Sources

---